These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37477769)

  • 21. Using drug scheduling to manage adverse events associated with hedgehog pathway inhibitors for basal cell carcinoma.
    Lear JT; Dummer R; Guminski A
    Oncotarget; 2021 Dec; 12(26):2531-2540. PubMed ID: 34966484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sonidegib for the Treatment of Advanced Basal Cell Carcinoma.
    Brancaccio G; Pea F; Moscarella E; Argenziano G
    Front Oncol; 2020; 10():582866. PubMed ID: 33194718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of Vismodegib for the Treatment of Orbital and Advanced Periocular Basal Cell Carcinoma.
    Eiger-Moscovich M; Reich E; Tauber G; Berliner O; Priel A; Ben Simon G; Elkader AA; Yassur I
    Am J Ophthalmol; 2019 Nov; 207():62-70. PubMed ID: 31077664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experience with sonidegib in patients with advanced basal cell carcinoma: case reports.
    Puig S; Serra-Guillén C; Pérez-Pastor G; Martínez-Domenech Á; Fernández-de-Misa Cabrera R
    Drugs Context; 2022; 11():. PubMed ID: 35677182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benefit-risk assessment of sonidegib and vismodegib in the treatment of locally advanced basal cell carcinoma.
    García Ruiz AJ; García-Agua Soler N; Herrera Acosta E; Zalaudek I; Malvehy J
    Drugs Context; 2022; 11():. PubMed ID: 35912002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sonidegib in the Treatment of Locally Advanced Basal Cell Carcinoma.
    Sanmartín O; Llombart B; Carretero Hernández G; Flórez Menéndez Á; Botella-Estrada R; Herrera Ceballos E; Puig S
    Actas Dermosifiliogr (Engl Ed); 2021 Apr; 112(4):295-301. PubMed ID: 33197438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib.
    Chang AL; Solomon JA; Hainsworth JD; Goldberg L; McKenna E; Day BM; Chen DM; Weiss GJ
    J Am Acad Dermatol; 2014 Jan; 70(1):60-9. PubMed ID: 24189279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vismodegib in Locally Advanced Basal Cell Carcinoma in Slovenia.
    Mesti T; Sever M; Ocvirk J
    Dermatology; 2023; 239(1):158-164. PubMed ID: 35896082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of Glioma-associated oncogene homolog 1 as biomarker with sonidegib in advanced basal cell carcinoma.
    Dummer R; Liu L; Squittieri N; Gutzmer R; Lear J
    Oncotarget; 2020 Sep; 11(37):3473-3483. PubMed ID: 32973971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral Hedgehog Pathway Inhibition as a Means for Ocular Salvage in Locally Advanced Intraorbital Basal Cell Carcinoma.
    Mathis J; Doerr T; Lin E; Ibrahim SF
    Dermatol Surg; 2019 Jan; 45(1):17-25. PubMed ID: 30586344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vismodegib and Sonidegib in Locally Advanced and Metastatic Basal Cell Carcinoma: Update on Hedgehog Pathway Inhibitors.
    Kurnia Wijaya J; Djawad K; Wahab S; Nurdin A; Irawan Anwar A
    Actas Dermosifiliogr; 2022 May; 113(5):443-450. PubMed ID: 35697404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hedgehog Pathway Inhibitor Therapy for Locally Advanced and Metastatic Basal Cell Carcinoma: A Systematic Review and Pooled Analysis of Interventional Studies.
    Jacobsen AA; Aldahan AS; Hughes OB; Shah VV; Strasswimmer J
    JAMA Dermatol; 2016 Jul; 152(7):816-24. PubMed ID: 27096888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential pharmacology and clinical utility of sonidegib in advanced basal cell carcinoma.
    Wahid M; Jawed A; Dar SA; Mandal RK; Haque S
    Onco Targets Ther; 2017; 10():515-520. PubMed ID: 28182134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-Dose Vismodegib as Maintenance Therapy After Locally Advanced Basal Cell Carcinoma Complete Remission: High Efficacy with Minimal Toxicity.
    Scalvenzi M; Cappello M; Costa C; Fabbrocini G; Luciano M; Villani A
    Dermatol Ther (Heidelb); 2020 Jun; 10(3):465-468. PubMed ID: 32240528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sonidegib and vismodegib in the treatment of patients with locally advanced basal cell carcinoma: a joint expert opinion.
    Dummer R; Ascierto PA; Basset-Seguin N; Dréno B; Garbe C; Gutzmer R; Hauschild A; Krattinger R; Lear JT; Malvehy J; Schadendorf D; Grob JJ
    J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):1944-1956. PubMed ID: 31990414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The safety and efficacy of sonidegib for the treatment of locally advanced basal cell carcinoma.
    Collier NJ; Ali FR; Lear JT
    Expert Rev Anticancer Ther; 2016 Oct; 16(10):1011-8. PubMed ID: 27636236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vismodegib for Locally Advanced Periocular and Orbital Basal Cell Carcinoma: A Review of 15 Consecutive Cases.
    Wong KY; Fife K; Lear JT; Price RD; Durrani AJ
    Plast Reconstr Surg Glob Open; 2017 Jul; 5(7):e1424. PubMed ID: 28831360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hedgehog pathway inhibition in advanced basal cell carcinoma: latest evidence and clinical usefulness.
    Silapunt S; Chen L; Migden MR
    Ther Adv Med Oncol; 2016 Sep; 8(5):375-82. PubMed ID: 27583029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retrospective Real-Life Data, Efficacy and Safety of Vismodegib Treatment in Patients with Advanced and Multiple Basal Cell Carcinoma: 3-Year Experience from a Spanish Center.
    Ayén-Rodríguez A; Linares-González L; Llamas-Segura C; Almazán-Fernández FM; Ruiz-Villaverde R
    Int J Environ Res Public Health; 2023 May; 20(10):. PubMed ID: 37239551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Investigator-Initiated Open-Label Trial of Sonidegib in Advanced Basal Cell Carcinoma Patients Resistant to Vismodegib.
    Danial C; Sarin KY; Oro AE; Chang AL
    Clin Cancer Res; 2016 Mar; 22(6):1325-9. PubMed ID: 26546616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.